Nuclear processes and cytokine synthesis
T-lymphocyte activation begins with profound intracellular changes. A key event at this stage is the translocation of the active transcription factor NFAT. It is important to understand that it travels strictly to the cell nucleus (bypassing the cytoplasm, Golgi apparatus, or endoplasmic reticulum).
Once in the nucleus, NFAT triggers gene expression, primarily the transcription of the interleukin-2 gene (IL-2 gene). As a result of this process, IL-2 messenger RNA (mRNA) is formed. The presence of mRNA serves as a direct instruction for the cellular apparatus, leading to the active synthesis and subsequent secretion of interleukin-2 protein into the extracellular space.
Pharmacological target: Glucocorticoids act at this foundational stage. Their mechanism of action involves the potent suppression of IL-2 gene expression and the blocking of pro-inflammatory cytokine synthesis directly at the cell nucleus level, halting the immune response at the very beginning.
Autocrine and paracrine stimulation
After interleukin-2 is secreted into the extracellular space, it begins to act as a potent catalyst for subsequent reactions. The secreted IL-2 binds to a specific IL-2 receptor located on the surface of the T-lymphocyte itself. Notably, the interaction occurs specifically with this receptor, and not with TNF-α, IL-1, or IL-4 receptors.
This binding provides autocrine (effect on itself) or paracrine (effect on neighboring cells) stimulation, repeatedly amplifying the signal for division.
Pharmacological target: To interrupt this stimulation loop, daclizumab is used. This is a monoclonal antibody that purposefully blocks the IL-2 receptor. By occupying the receptor, the drug makes the cell completely insensitive to stimulation by this cytokine.
Proliferation signaling pathway (mTOR)
Successful activation of the IL-2 receptor immediately triggers signal transduction inside the cell. The main conductor here is the intracellular kinase pathway mTOR (mammalian target of rapamycin). In this context, mTOR is activated specifically, rather than alternative cascades like MAPK/ERK, NF-κB, or JAK-STAT.
The function of the mTOR pathway is critically important for cell cycle control. This enzyme acts as a molecular switch that ensures the transition of the T-lymphocyte from the resting and initial growth phase ($G_1$) to the active DNA synthesis phase ($S$). Without this transition, cell division is physically impossible.
Pharmacological target: This signaling pathway is the point of action for sirolimus. The drug specifically inhibits mTOR, leading to an immediate arrest of the cell cycle and preventing further T-lymphocyte division.
Final proliferation and differentiation
If all checkpoints are passed and the cell cycle successfully completes, the final stage begins. Completion of the cycle leads to clonal proliferation (mass multiplication) and differentiation of T-lymphocytes. The cell follows the multiplication pathway specifically, avoiding scenarios such as apoptosis, chemotaxis, or anergy.
Pharmacological target: At the stage of direct division, cytostatic drugs come into play — azathioprine and mycophenolate. Their task is to suppress the synthesis of purines and DNA molecules. Since the creation of every new cell requires the doubling of genetic material, inhibiting purine synthesis reliably blocks proliferation.
To memorize the sites of drug action, use the chain "Nucleus — Receptor — Signal — DNA": Glucocorticoids work in the Nucleus (IL-2 gene), Daclizumab blocks the Receptor (IL-2), Sirolimus dampens the Signal (mTOR), and Azathioprine and Mycophenolate prevent DNA synthesis (purines).
Class and exam questions
Where exactly does the active NFAT factor translocate to initiate transcription?
The active transcription factor NFAT translocates strictly into the cell nucleus. There, it initiates gene expression, specifically triggering the transcription of the interleukin-2 gene.
What is the role of the mTOR pathway in the T-lymphocyte life cycle?
The intracellular mTOR kinase pathway regulates the cell cycle. Its main function is to ensure the transition of the cell from the resting and growth phase ($G_1$) to the DNA synthesis phase ($S$).
How do azathioprine and mycophenolate act at the proliferation stage?
These drugs act as cytostatics. They inhibit proliferation by suppressing the synthesis of purines and DNA, which are vital for cell division.
Which drug renders the cell insensitive to the action of IL-2?
Daclizumab. This is a monoclonal antibody that specifically blocks the IL-2 receptor on the surface of the T-lymphocyte, interrupting the pathway of autocrine and paracrine stimulation.
What else to study on this topic
- Mechanisms of activation of the transcription factor NFAT prior to its entry into the cell nucleus.
- Detailed structure and subunits of the specific IL-2 receptor.
- Features of the cell cycle phases ($G_1$ and $S$) in the context of clonal proliferation.
- Differences in the mechanisms of action of azathioprine and mycophenolate on purine synthesis.
- The role of mRNA in the translation and secretion of the interleukin-2 protein.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "T-lymphocyte Proliferation and Differentiation" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antigout drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.